Pediatric BMT Clinician

Discover Your Career at Emory University

Emory University is a leading research university that fosters excellence and attracts world-class talent to innovate today and prepare leaders for the future. We welcome candidates who can contribute to the excellence of our academic community.

Pediatric Blood and Marrow Transplantation

The Aflac Cancer & Blood Disorders Center of Children's Healthcare of Atlanta and the Emory University Department of Pediatrics invites interested applicants for a faculty level position in pediatric Blood and Marrow Transplantation. The Aflac Cancer & Blood Disorders Center provides a rich and collaborative environment for basic, clinical, and translational research and boasts a diverse faculty. The Blood and Marrow Transplant (BMT) Program is one of the largest pediatric BMT programs in the country, performing more than 80 lifesaving BMTs in 2024. The BMT program is an integral component of the Aflac Cancer & Blood Disorders Center, and currently includes 12 faculty members, with a broad range of basic, clinical and translational research.

Qualified candidates should be Board Certified/Eligible Hematologist/Oncologists, and preference will be given to applicants who wish to continue a career focused on clinical care in transplantation and cellular therapy. This is a clinical position, and research commitment is flexible depending on the candidate's qualifications. Rank of assistant or associate professor will depend on experience and accomplishments.

About the Aflac Cancer & Blood Disorders Center

The successful candidate will join one of the strongest pediatric hematology/oncology programs in the country.

• In 2024, the Aflac Cancer & Blood Disorders Center was ranked No. 12 in the nation for Pediatric Cancer by US News and World Report
• Each year our team cares for more than 170 newly diagnosed leukemia and lymphoma patients using a variety of treatment protocols, including blood and marrow transplant (BMT), hematopoietic stem cell transplant, chimeric antigen receptor (CAR)-T therapy, and Phase I and II clinical trials for patients whose cancer has relapsed or is not responding to treatment
• The Aflac Cancer & Blood Disorders Center has over 130 faculty and nearly 50 Advance Practice Providers (APPs), conducting basic, translational, cooperative group and investigator-initiated clinical research related to pediatric oncology and hematology disorders, with expertise in leukemias, lymphomas, brain tumors, neuroblastoma, sarcomas, rare tumors, renal tumors, CAR T-cell therapies, cancer survivorship, health services research, hemoglobinopathies and hemophilia.
• More than 9,000 children with cancer and blood disorders are treated annually at the Aflac Cancer & Blood Disorders Center
• The Aflac pediatric oncology program sees ~500 new cancer diagnoses each year. Aflac is the pediatric component of the Winship Cancer Institute of Emory University.
• The Aflac pediatric hematology program is one of the largest in the country (including >2,000 active patients with sickle cell disease, and >1,000 with bleeding or clotting disorders)
• The Aflac blood and marrow transplantation program performs ~80 transplants each year, and is one of the leaders in curative therapies for hemoglobinopathies.
• In 2024, Aflac faculty generated $31M in extramural funding, including more than $17M from the NIH
• The Aflac fellowship program accepts 6 fellows each year for intensive clinical and research training in pediatric hematology/oncology. We are one of the few pediatric programs with an NIH-funded T32 training grant in non-malignant hematology.
• The Aflac Developmental Therapeutics Program includes Leukemia and Lymphoma faculty from the High-Risk Leukemia team and offers a wide portfolio of clinical trials from cooperative groups, industry partners, and investigator-initiated studies, and has a larger referral base in the southeastern United States. Aflac is a member of the COG Pediatric Early Phase Clinical Trials Network (PEP-CTN), NANT, TACL, and PBTC.
• The MIBG and Relapsed Neuroblastoma Program is the largest in the southeast and has treated ~100 patients with therapeutic MIBG since its inception in 2013.

This position offers a wealth of opportunities for research collaborations within the Department of Pediatrics, Winship Cancer Institute, Grady Hospital as well as with Emory basic science departments, the Rollins School of Public Health, the Georgia Institute of Technology, Morehouse School of Medicine and the Centers for Disease Control and Prevention.

Successful candidates will have:

• MD, MD/PhD, or DO degrees
• Must be Board Certified in Pediatric Hematology-Oncology
• Must be currently licensed as a physician and eligible for licensure as a physician in the State of Georgia
• A history of clinical excellence/achievement

Salary and rank of Assistant Professor or Associate Professor at Emory University School of Medicine will be commensurate with experience and accomplishments. The primary focus of this position will be an emphasis on clinical service including inpatient and outpatient responsibilities, and administrative duties.

Additional Details

Employment will be in the Emory + Children's Pediatric Institute. The Emory + Children's Pediatric Institute is an affiliation between Emory University and Children's Healthcare of Atlanta that is improving the lives of children in Georgia and beyond. The Pediatric Institute combines the unique strengths and resources of each institution in support of our three-part academic missions of providing outstanding clinical care, conducting innovative basic science discovery and clinical research, and coordinating exceptional education of the future healthcare workforce. Our physicians, researchers, and educators have created a model where leadership, commitment and quality are fundamental components of success. Together, we are transforming pediatrics by achieving new levels of clinical excellencedriven by research, teaching and wellness. We look forward to our future together.

NOTE: Position tasks are required to be performed in-person at an Emory University location; working remote is not an option. Emory reserves the right to change this status with notice to employee.

Additional Details

Emory is an equal opportunity employer, and qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, disability, protected veteran status or other characteristics protected by state or federal law. Emory University does not discriminate in admissions, educational programs, or employment, including recruitment, hiring, promotions, transfers, discipline, terminations, wage and salary administration, benefits, and training. Students, faculty, and staff are assured of participation in university programs and in the use of facilities without such discrimination. Emory University complies with Section 503 of the Rehabilitation Act of 1973, the Vietnam Era Veteran's Readjustment Assistance Act, and applicable executive orders, federal and state regulations regarding nondiscrimination, equal opportunity, and affirmative action (for protected veterans and individuals with disabilities). Inquiries regarding this policy should be directed to the Emory University Department of Equity and Civil Rights Compliance, 201 Dowman Drive, Administration Building, Atlanta, GA 30322. Telephone: View phone number on click.appcast.io (V) | View phone number on click.appcast.io (TDD).

Emory University is committed to ensuring equal access and providing reasonable accommodations to qualified individuals with disabilities upon request. To request this document in an alternate format or to seek a reasonable accommodation, please contact the Department of Accessibility Services at View email address on click.appcast.io or call View phone number on click.appcast.io (Voice) | View phone number on click.appcast.io (TDD). We kindly ask that requests be made at least seven business days in advance to allow adequate time for coordination.